UC
UCB S.A.
UCBJF · OTC
$235.10 -5.35% (-$13.30)
1M -4.93%
Market Cap 41.1B €
P/E Ratio 26.40x
Div. Yield 0.68%
ROE 14.76%
Bulios Fair Price
$333.52
41.9% upside
Trenutna cena
$235.1
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica UCBJF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
48 /100
Fair P/E 26.40x
PEG 0.57x
EV/EBITDA 20.47x
Growth
87 /100
Growing EPS growth 56.24%
Book val. growth 6.22%
Rev. growth 11.94%
Profitability
100 /100
Strong Gross margin 74.29%
FCF margin 24.31%
Net margin 20.13%
Quality
65 /100
Average ROIC 12.43%
Asset turnover 0.43x
ROE 14.76%
Debt
95 /100
Low Debt/Equity 0.21x
Net debt/EBITDA -0.00x
Current ratio 1.38x
Stability
36 /100
Moderate Beta 0.20x
Profitable years 6
Rev. volatility 15.77%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o UCBJF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Christophe Tellier
Employees
10,117
Headquarters
Brussels
Prihajajoči dogodki
25 FEB.
Earnings
Upcoming earnings report